Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.97 USD | -0.80% | -2.34% | -35.69% |
Apr. 09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Apr. 09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.69% | 134M | |
+17.91% | 47.02B | |
+48.77% | 41.86B | |
+0.84% | 41.76B | |
-4.27% | 28.8B | |
+11.91% | 26.05B | |
-21.38% | 19.15B | |
+4.30% | 12.55B | |
+28.43% | 12.34B | |
-4.38% | 11.82B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals Completes Enrollment of 190 People in Phase 3 Trial of Tamibarotene